2022
DOI: 10.3389/fmolb.2022.849363
|View full text |Cite
|
Sign up to set email alerts
|

Mapping CAR T-Cell Design Space Using Agent-Based Models

Abstract: Chimeric antigen receptor (CAR) T-cell therapy shows promise for treating liquid cancers and increasingly for solid tumors as well. While potential design strategies exist to address translational challenges, including the lack of unique tumor antigens and the presence of an immunosuppressive tumor microenvironment, testing all possible design choices in vitro and in vivo is prohibitively expensive, time consuming, and laborious. To address this gap, we extended the modeling framework ARCADE (Agent-based Repre… Show more

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
9
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
7
3

Relationship

1
9

Authors

Journals

citations
Cited by 16 publications
(9 citation statements)
references
References 104 publications
(235 reference statements)
0
9
0
Order By: Relevance
“…Developing this platform could expand in silico methods in synthetic immunotherapy and create a pipeline similar to how GJSM is currently used to test circuit designs for synthetic development 33 . While computational efforts for synthetic immunotherapy begin with this study, similar efforts are at least underway for regular CAR T cell immunotherapy [58][59][60][61][62] .…”
Section: Discussionmentioning
confidence: 99%
“…Developing this platform could expand in silico methods in synthetic immunotherapy and create a pipeline similar to how GJSM is currently used to test circuit designs for synthetic development 33 . While computational efforts for synthetic immunotherapy begin with this study, similar efforts are at least underway for regular CAR T cell immunotherapy [58][59][60][61][62] .…”
Section: Discussionmentioning
confidence: 99%
“…The colony and tissue contexts describe simulations comprised of solely cancer cells and a combination of cancer and healthy cell populations, respectively. Prior work highlighted differences in emergent behavior between colony and tissue contexts (Yu and Bagheri, 2016, 2021; Prybutok et al, 2022b).…”
Section: Methodsmentioning
confidence: 99%
“…Additionally, an innovative use of a 2D Gaussian kernel density to smooth the discrete spatial distribution of the cells allowed the authors to introduce a new way to locate the boundaries of the tumor-invasive front from digital pathology images. A different therapeutic approach, namely Chimeric Antigen Receptor (CAR) T-cell therapy, was modeled and investigated by Prybutok et al 49 Simulations of both a dish and a tissue (where nutrients are thus provided by the vasculature) resulted in the identification of the best treatment strategy. This maximizes cancer cell death by CAR T-cells while minimizing the elimination of low-level antigen-expressing healthy cells.…”
Section: Agent-based Modeling In Cancer Biomedicinementioning
confidence: 99%